Opaleye Management as of June 30, 2014
Portfolio Holdings for Opaleye Management
Opaleye Management holds 27 positions in its portfolio as reported in the June 2014 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Chimerix (CMRX) | 14.9 | $17M | 790k | 21.94 | |
Retrophin | 12.3 | $14M | 1.2M | 11.74 | |
Ariad Pharmaceuticals | 9.1 | $11M | 1.7M | 6.37 | |
Pharmacyclics | 7.7 | $9.0M | 100k | 89.71 | |
GenMark Diagnostics | 5.8 | $6.8M | 500k | 13.53 | |
Bind Therapeutics | 5.6 | $6.5M | 492k | 13.18 | |
Inspiremd Com New | 5.5 | $6.4M | 2.2M | 2.95 | |
Cempra | 4.7 | $5.4M | 505k | 10.73 | |
Clovis Oncology | 4.6 | $5.4M | 130k | 41.30 | |
Agios Pharmaceuticals (AGIO) | 4.5 | $5.3M | 115k | 45.82 | |
Cardiovascular Systems | 3.6 | $4.2M | 135k | 31.16 | |
Catalyst Pharmaceutical Partners (CPRX) | 3.0 | $3.5M | 1.4M | 2.53 | |
Insys Therapeutics Com New | 2.3 | $2.7M | 86k | 31.24 | |
Tetraphase Pharmaceuticals | 2.0 | $2.3M | 170k | 13.49 | |
Mazor Robotics Ltd. equities | 1.8 | $2.1M | 120k | 17.57 | |
Ultragenyx Pharmaceutical (RARE) | 1.7 | $2.0M | 45k | 44.89 | |
Evoke Pharma | 1.7 | $2.0M | 243k | 8.09 | |
Recro Pharma (SCTL) | 1.5 | $1.8M | 220k | 8.01 | |
Celgene Corp Right 12/31/2030 | 1.5 | $1.7M | 660k | 2.60 | |
Karyopharm Therapeutics (KPTI) | 1.2 | $1.4M | 30k | 46.57 | |
Biolinerx Ltd-spons | 1.2 | $1.4M | 650k | 2.08 | |
Codexis (CDXS) | 1.0 | $1.2M | 820k | 1.46 | |
Celator Pharmaceuticals | 0.9 | $1.1M | 338k | 3.17 | |
Kalobios Pharmaceuticals | 0.6 | $730k | 320k | 2.28 | |
Alnylam Pharmaceuticals (ALNY) | 0.4 | $455k | 7.2k | 63.19 | |
Kips Bay Med | 0.3 | $355k | 772k | 0.46 | |
Prothena (PRTA) | 0.3 | $295k | 13k | 22.51 |